Letteratura scientifica selezionata sul tema "B14"
Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili
Consulta la lista di attuali articoli, libri, tesi, atti di convegni e altre fonti scientifiche attinenti al tema "B14".
Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.
Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.
Articoli di riviste sul tema "B14"
Pertiwi, Hutami Indah, Sri Wilarso Budi R. e Arum Sekar Wulandari. "PENGARUH FUNGI MIKORIZA ARBUSKULA (FMA) DAN MYCORRHIZAL HELPER BACTERIA (MHB) TERHADAP PERTUMBUHAN JABON (Anthocepalus cadamba Roxb.) The Effect of Arbuscula Mycorrhizal Fungi (AMF) and Mycorrhizal Helper Bacteria (MHB) on Growth of Jabon". Journal of Tropical Silviculture 8, n. 3 (19 marzo 2018): 147–53. http://dx.doi.org/10.29244/j-siltrop.8.3.147-153.
Testo completoKarimzadeh, Z., e M. H. Tangestani. "APPLICATION OF WORLDVIEW-3 DATA IN ALTERATION MINERAL MAPPING IN CHADORMALU AREA, CENTRAL IRAN". ISPRS - International Archives of the Photogrammetry, Remote Sensing and Spatial Information Sciences XLII-4/W18 (18 ottobre 2019): 589–96. http://dx.doi.org/10.5194/isprs-archives-xlii-4-w18-589-2019.
Testo completoHogue, Richard, e Alain Asselin. "Detection of 10 additional pathogenesis-related (b) proteins in intercellular fluid extracts from stressed 'Xanthi-nc' tobacco leaf tissue". Canadian Journal of Botany 65, n. 3 (1 marzo 1987): 476–81. http://dx.doi.org/10.1139/b87-057.
Testo completoLan, Ruiting, Brad Lumb, David Ryan e Peter R. Reeves. "Molecular Evolution of Large Virulence Plasmid inShigella Clones and EnteroinvasiveEscherichia coli". Infection and Immunity 69, n. 10 (1 ottobre 2001): 6303–9. http://dx.doi.org/10.1128/iai.69.10.6303-6309.2001.
Testo completoNaiborhu, Sri Ayu Agustina, Wan Arfiani Barus e Efrida Lubis. "PERTUMBUHAN DAN HASIL TANAMAN KAILAN DENGAN PEMBERIAN BEBERAPA KOMBINASI JENIS DAN DOSIS PUPUK BOKASHI". Jurnal Rhizobia 3, n. 1 (13 febbraio 2021): 58–66. http://dx.doi.org/10.36985/rhizobia.v10i1.465.
Testo completoBagchi, Parikshit, Christopher Paul Walczak e Billy Tsai. "The Endoplasmic Reticulum Membrane J Protein C18 Executes a Distinct Role in Promoting Simian Virus 40 Membrane Penetration". Journal of Virology 89, n. 8 (28 gennaio 2015): 4058–68. http://dx.doi.org/10.1128/jvi.03574-14.
Testo completoLi, Qian Shu, Feng Long Gu e Au Chin Tang. "Quantum chemistry study on B14, B142?, and B14H142?" International Journal of Quantum Chemistry 50, n. 3 (15 aprile 1994): 173–79. http://dx.doi.org/10.1002/qua.560500302.
Testo completoSavoy, L. A., R. M. L. Jones, S. Pochon, J. G. Davies, A. V. Muir, R. E. Offord e K. Rose. "Identification by fast atom bombardment mass spectrometry of insulin fragments produced by insulin proteinase". Biochemical Journal 249, n. 1 (1 gennaio 1988): 215–22. http://dx.doi.org/10.1042/bj2490215.
Testo completoChen, Ron A. J., Nathalie Jacobs e Geoffrey L. Smith. "Vaccinia virus strain Western Reserve protein B14 is an intracellular virulence factor". Journal of General Virology 87, n. 6 (1 giugno 2006): 1451–58. http://dx.doi.org/10.1099/vir.0.81736-0.
Testo completoMetakovsky, Eugene, Laura Pascual, Patrizia Vaccino, Viktor Melnik, Marta Rodriguez-Quijano, Yulia Popovych, Sabina Chebotar e William John Rogers. "Heteroalleles in Common Wheat: Multiple Differences between Allelic Variants of the Gli-B1 Locus". International Journal of Molecular Sciences 22, n. 4 (12 febbraio 2021): 1832. http://dx.doi.org/10.3390/ijms22041832.
Testo completoTesi sul tema "B14"
Chen, Ron An-Jung. "Characterisation of the B14 protein in vaccinia virus strain Western Reserve". Thesis, Imperial College London, 2006. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.428719.
Testo completoMcCoy, Laura Ellen. "Vaccinia virus protein B14, an inhibitor of NF-κB activation, and its counterpart in MVA". Thesis, Imperial College London, 2010. http://hdl.handle.net/10044/1/5590.
Testo completoRibeiro, Maria Carolina de Oliveira. "Caracterização do Pediococcus acidilactic b14 quanto às propriedades probióticas e sua associação com lactobacillus acidophilus ATCC 4356 com aplicação em sobremesa com soja aerada potencialmente simbiótica". reponame:Repositório Institucional da UFPR, 2013. http://hdl.handle.net/1884/30592.
Testo completoSvangren, Henrik. "Konceptstudie av kassadisk B10/B11". Thesis, Jönköping University, JTH, Mechanical Engineering, 2007. http://urn.kb.se/resolve?urn=urn:nbn:se:hj:diva-942.
Testo completoThis master’s thesis report is a summary of the analysis performed together with ITAB Shop Concept located in Jönköping, Sweden. As a last element of the Master’s program at the School of Engineering, this 20 point level D thesis project has been the final work to bring my education to an end.
ITAB Shop Concept expressed an aspiration that the Shop Counter Program B10/B11 should undergo an analysis to point out and possibly lead to improvement.
Through interviews and data collection proposals for possible improvements has been drawn up and the analysis points out current deficiencies. By following the idea generation, proposals to solutions for every individual problem is presented. These proposals are weighted and compared to specified requirements.
The result is built up through a number of changes in the Shop Counter Program, partly by suggestions on reduction of part, but also how the Shop Counter can be re-designed.
Sánchez, Huamaní Juan Pablo. "Eficacia analgésica de diclofenaco más vitaminas b1, b6 y b12 en comparación a sólo diclofenaco en cirugía de tercera molar inferior". Bachelor's thesis, Universidad Nacional Mayor de San Marcos, 2015. https://hdl.handle.net/20.500.12672/4541.
Testo completo--- This thesis is based on a single-blind, non-randomized clinical trial which took place in the oral and maxillofacial surgery service of the Hipólito Unanue National Hospital, of which objective was to determine if the therapy using diclofenac plus B vitamins is better than the therapy using only diclofenac in patients subjected to elective surgery of inferior third molar. Two groups were formed, a group received diclofenac plus B vitamins and the other group received diclofenac only. The main variable was the intensity of pain measured after 1, 3, 6, 9, 12 and 24 hours the surgery had finished using a verbal graphic scale (0-100); the secondary variables were the time for rescue analgesics consumption and the amount of rescue analgesics taken in the postoperative period. Thirty patients completed the study, fifteen of them received diclofenac (75 mg) plus B vitamins (B1: 100 mg, B6: 100 mg and B12: 10 mg) and other fifteen patients received only diclofenac (75 mg). Both therapies were administered by intramuscular route once the surgery was finished. The results showed that by adding B vitamins to diclofenac improved the analgesic effectiveness of diclofenac in the main variable but there were no statistically significant differences. Keywords: diclofenac – b vitamins – dental surgery – impacted third molar
Tesis
Alfaro, Carbajal Cesar Alberto. "Consulting report – Agencia B12". Master's thesis, Pontificia Universidad Católica del Perú, 2019. http://hdl.handle.net/20.500.12404/15246.
Testo completoAgencia B12 es una subsidiaria de un grupo español con operaciones en México, Perú y España. Agencia B12 desarrolla sus operaciones principalmente en marketing digital y servicio de llamadas. Este tipo de servicios ofrecidos por la firma son operados en las compañías de telecomunicaciones (como Movistar, Claro, Bitel and Entel Perú), Agencia B12 trabaja en colaboración con las principales compañías en sector de telecomunicaciones, sin embargo, actualmente se encuentra trabajando con algunas compañías que son de otras industrias como Direct tv y el Banco Pichincha. El actual propósito de Agencia B12 es diversificar su portafolio de servicios con la finalidad de poder adquirir nuevas fuentes de ingreso. Los nuevos proyectos que Agencia B12 desea desarrollar son debido a que su portafolio de clientes está fuertemente ligado a la industria de telecomunicaciones, en respuesta a esta situación Agencia B12 desea lanzar Digital collection con el objetivo de expandir su portafolio de clientes, aventurándose en el mercado cobranza, trabajando con nuevos clientes, en este caso las entidades financieras. Si bien, el proyecto inicialmente será lanzado como prototipo en Perú, el deseo de Agencia B12 es expandir este servicio hacia otras sucursales.
Tesis
Oliveira, Gersilene Valente de. "Vitaminas B1, B6, B12 e Complexo B na prevenÃÃo da discinesia orofacial induzida por haloperidol em ratos: avaliaÃÃo comportamental e mecanismos associados". Universidade Federal do CearÃ, 2015. http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=16133.
Testo completoA Discinesia tardia (DT) à caracterizada por movimentos involuntÃrios, principalmente na parte inferior da face, prÃximos da boca, com espasmos que podem ser leves ou severos. à uma alteraÃÃo motora grave relacionada, mas nÃo restrita à terapia antipsicÃtica. Tratamentos com antipsicÃticos principalmente os da classe dos tÃpicos, como o haloperidol (HAL) aumentam os riscos de DT. A fisiopatologia da DT à associada a um desequilÃbrio em sistemas de neurotransmissÃo, dentre eles dopaminÃrgico e colinÃrgico, bem como com desequilÃbrio oxidativo, principalmente em Ãreas cerebrais relacionadas ao controle do movimento, como o corpo estriado. As vitaminas (vit.) B, por sua vez, apresentam efeitos antioxidantes sendo cofatores para enzimas relacionadas à sÃntese de neurotransmissores. Neste contexto, o presente trabalho teve como objetivo determinar os efeitos preventivos das vit. B1, B6, B12 ou Complexo B na discinesia orofacial (DO) induzida por HAL em ratos. Foram utilizados ratos Wistar machos tratados por via intraperitoneal com HAL (1 mg/kg, i.p.) por 21 dias ou concomitantemente com HAL e as vit. B1 (60 mg/kg), B6 (60 mg/kg) ou B12 (0,6 mg/kg) por via subcutÃnea, sozinhas ou em associaÃÃo (complexo B). O complexo B consistiu na mistura das 3 vitaminas em iguais proporÃÃes. Um grupo de animais foi administrado clozapina (25 mg/kg), um antipsicÃtico atÃpico nÃo relacionado ao desenvolvimento de DO. Os testes comportamentais foram realizados apÃs 30 minutos no 1Â, 7 e 21 dias de administraÃÃo das fÃrmacos e consistiram na determinaÃÃo da atividade locomotora, catalepsia e movimentos de mastigaÃÃo no vazio. No 21 dia os animais foram sacrificados e retiradas Ãreas cerebrais para as anÃlises neuroquÃmicas e de expressÃo para tirosina hidroxilase (TH), receptores dopaminÃrgicos D1 e D2 e receptor muscarÃnico M1. Os resultados mostraram que o HAL aumentou o tempo de catalepsia no dia 7 e causou DO no dia 21. A administraÃÃo das vit. B (B1: B6: B12) sozinhas ou em associaÃÃo, juntamente com HAL, preveniu o desenvolvimento de DO e em menor extensÃo da catalepsia. O efeito preventivo das vit. B foi acompanhado por restauraÃÃo dos nÃveis de glutationa reduzida (GSH) e peroxidaÃÃo lipÃdica. AlÃm dos efeitos antioxidantes, as vit. B aumentaram a atividade da enzima acetilcolinesterase (AChE) em todas as Ãreas cerebrais estudadas, com o incremento mÃximo de atividade observada no hipocampo de animais co-tratados com vit. B12 e coquetel de vit. B. A clozapina nÃo induziu DO e aumentou a atividade AChE semelhante para os grupos co-administrados com vit. B e HAL. A anÃlise da expressÃo de receptores e enzimas relacionadas à sÃntese de neurotransmissores no corpo estriado por PCR-RT revelou que o HAL foi capaz de aumentar a expressÃo de receptores dopaminÃrgicos D1 e D2 e reduzir a expressÃo dos receptores muscarÃnicos M1. A expressÃo da tirosina hidroxilase (TH), passo limitante para a sÃntese de dopamina, se apresentou reduzida pelo HAL. Os dados sugerem que as vitamina do complexo B sÃo capazes de prevenir as alteraÃÃes induzidas pelo HAL apresentando, portanto, um papel promissor na prevenÃÃo de DO associada ao uso desta fÃrmaco.
Tardive dyskinesia (TD) is characterized by involuntary movements, mostly at lower face, near the mouth, with convulsion that can be light or hard. Is one severe disorder related, but restricted the antipsychotic therapy. Antipsychotic treatments above all the class of typical, like haloperidol (HAL) increase the risk of TD. The pathophysiology of TD is associated to a instability in neurotransmission system, such as dopaminergic and cholinergic, among others, as well as with oxidative instability mainly in brain areas related to the control of movement, as the striatum. B vitamins, in turn, show antioxidants effect and are cofactors to enzymes related to the synthesis of neurotransmitters. In this context, the present study aimed to determine the preventive effects of B1, B6, B12 vitamins or B complex against orofacial dyskinesia (OD) induced by HAL in rats. To do this male Wistar rats were intraperitoneally administered HAL (1 mg/kg, i.p.) for 21 days or concomitantly received HAL, B1 (60 mg/kg), B6 (60 mg/kg) or B12 (0,6 mg/kg) vitamin subcutaneously alone or in association. B complex consisted in the mix of 3 vitamins in equal proportions. One group of animals was administered with clozapine (25 mg/kg), an atypical antipsychotic not related to the development of OD. Behavioral tests were performed at the 1st, 7th and 21st days of drugs administration. The behavioral tests performed were locomotor activity, catalepsy and chewing vacuous movements. At 21st day the animals were sacrificed and had their brain areas dissected for neurochemical analysis. The results showed that HAL increased catalepsy time at 7th day and OD at 21st day. Administration of B vitamins (B1:B6:B12) alone or in association, together with HAL, prevented the development of OD and in a lower extension, catalepsy. Preventive effect of B vitamins was accompanied by restoration of the levels of reduced glutathione (GSH) and lipid peroxidation. Beyond the antioxidant effects, B vitamins increased the activity of the enzyme acetylcholinesterase (AChE) in all brain areas studied, with the maximum increase of activity observed in the hippocampus of animals co-administered with B12 vitamins and B vitamins cocktail. Clozapine did not induce OD and increase in the activity of AChE. Analysis of the expression of receptors and enzymes related to the synthesis of neurotransmitters in striatum by PCR-RT revealed that HAL increased the expression of the dopaminergic receptors D1 and D2 and reduce an expression of the muscarinic receptors M1. Haloperidol decreased the expression of tyrosine hydroxylase (TH), a limiting step for the synthesis of dopamine. Taken together the results suggest that B vitamins prevented changes induced by HAL, presenting thus a promising role as a preventive approach against HAL-induced OD.
Oliveira, Gersilene Valente de. "Vitaminas B1, B6, B12 e Complexo B na prevenção da discinesia orofacial induzida por haloperidol em ratos : avaliação comportamental e mecanismos associados". reponame:Repositório Institucional da UFC, 2015. http://www.repositorio.ufc.br/handle/riufc/15726.
Testo completoSubmitted by denise santos (denise.santos@ufc.br) on 2016-03-23T11:46:26Z No. of bitstreams: 1 2015_tese_gvoliveira.pdf: 1674290 bytes, checksum: 228729dd06081b0ef7e89c28e47625d3 (MD5)
Approved for entry into archive by denise santos(denise.santos@ufc.br) on 2016-03-23T13:08:17Z (GMT) No. of bitstreams: 1 2015_tese_gvoliveira.pdf: 1674290 bytes, checksum: 228729dd06081b0ef7e89c28e47625d3 (MD5)
Made available in DSpace on 2016-03-23T13:08:17Z (GMT). No. of bitstreams: 1 2015_tese_gvoliveira.pdf: 1674290 bytes, checksum: 228729dd06081b0ef7e89c28e47625d3 (MD5) Previous issue date: 2015
Tardive dyskinesia (TD) is characterized by involuntary movements, mostly at lower face, near the mouth, with convulsion that can be light or hard. Is one severe disorder related, but restricted the antipsychotic therapy. Antipsychotic treatments above all the class of typical, like haloperidol (HAL) increase the risk of TD. The pathophysiology of TD is associated to a instability in neurotransmission system, such as dopaminergic and cholinergic, among others, as well as with oxidative instability mainly in brain areas related to the control of movement, as the striatum. B vitamins, in turn, show antioxidants effect and are cofactors to enzymes related to the synthesis of neurotransmitters. In this context, the present study aimed to determine the preventive effects of B1, B6, B12 vitamins or B complex against orofacial dyskinesia (OD) induced by HAL in rats. To do this male Wistar rats were intraperitoneally administered HAL (1 mg/kg, i.p.) for 21 days or concomitantly received HAL, B1 (60 mg/kg), B6 (60 mg/kg) or B12 (0,6 mg/kg) vitamin subcutaneously alone or in association. B complex consisted in the mix of 3 vitamins in equal proportions. One group of animals was administered with clozapine (25 mg/kg), an atypical antipsychotic not related to the development of OD. Behavioral tests were performed at the 1st, 7th and 21st days of drugs administration. The behavioral tests performed were locomotor activity, catalepsy and chewing vacuous movements. At 21st day the animals were sacrificed and had their brain areas dissected for neurochemical analysis. The results showed that HAL increased catalepsy time at 7th day and OD at 21st day. Administration of B vitamins (B1:B6:B12) alone or in association, together with HAL, prevented the development of OD and in a lower extension, catalepsy. Preventive effect of B vitamins was accompanied by restoration of the levels of reduced glutathione (GSH) and lipid peroxidation. Beyond the antioxidant effects, B vitamins increased the activity of the enzyme acetylcholinesterase (AChE) in all brain areas studied, with the maximum increase of activity observed in the hippocampus of animals co-administered with B12 vitamins and B vitamins cocktail. Clozapine did not induce OD and increase in the activity of AChE. Analysis of the expression of receptors and enzymes related to the synthesis of neurotransmitters in striatum by PCR-RT revealed that HAL increased the expression of the dopaminergic receptors D1 and D2 and reduce an expression of the muscarinic receptors M1. Haloperidol decreased the expression of tyrosine hydroxylase (TH), a limiting step for the synthesis of dopamine. Taken together the results suggest that B vitamins prevented changes induced by HAL, presenting thus a promising role as a preventive approach against HAL-induced OD.
A Discinesia tardia (DT) é caracterizada por movimentos involuntários, principalmente na parte inferior da face, próximos da boca, com espasmos que podem ser leves ou severos. É uma alteração motora grave relacionada, mas não restrita à terapia antipsicótica. Tratamentos com antipsicóticos principalmente os da classe dos típicos, como o haloperidol (HAL) aumentam os riscos de DT. A fisiopatologia da DT é associada a um desequilíbrio em sistemas de neurotransmissão, dentre eles dopaminérgico e colinérgico, bem como com desequilíbrio oxidativo, principalmente em áreas cerebrais relacionadas ao controle do movimento, como o corpo estriado. As vitaminas (vit.) B, por sua vez, apresentam efeitos antioxidantes sendo cofatores para enzimas relacionadas à síntese de neurotransmissores. Neste contexto, o presente trabalho teve como objetivo determinar os efeitos preventivos das vit. B1, B6, B12 ou Complexo B na discinesia orofacial (DO) induzida por HAL em ratos. Foram utilizados ratos Wistar machos tratados por via intraperitoneal com HAL (1 mg/kg, i.p.) por 21 dias ou concomitantemente com HAL e as vit. B1 (60 mg/kg), B6 (60 mg/kg) ou B12 (0,6 mg/kg) por via subcutânea, sozinhas ou em associação (complexo B). O complexo B consistiu na mistura das 3 vitaminas em iguais proporções. Um grupo de animais foi administrado clozapina (25 mg/kg), um antipsicótico atípico não relacionado ao desenvolvimento de DO. Os testes comportamentais foram realizados após 30 minutos no 1º, 7º e 21º dias de administração das fármacos e consistiram na determinação da atividade locomotora, catalepsia e movimentos de mastigação no vazio. No 21° dia os animais foram sacrificados e retiradas áreas cerebrais para as análises neuroquímicas e de expressão para tirosina hidroxilase (TH), receptores dopaminérgicos D1 e D2 e receptor muscarínico M1. Os resultados mostraram que o HAL aumentou o tempo de catalepsia no dia 7 e causou DO no dia 21. A administração das vit. B (B1: B6: B12) sozinhas ou em associação, juntamente com HAL, preveniu o desenvolvimento de DO e em menor extensão da catalepsia. O efeito preventivo das vit. B foi acompanhado por restauração dos níveis de glutationa reduzida (GSH) e peroxidação lipídica. Além dos efeitos antioxidantes, as vit. B aumentaram a atividade da enzima acetilcolinesterase (AChE) em todas as áreas cerebrais estudadas, com o incremento máximo de atividade observada no hipocampo de animais co-tratados com vit. B12 e coquetel de vit. B. A clozapina não induziu DO e aumentou a atividade AChE semelhante para os grupos co-administrados com vit. B e HAL. A análise da expressão de receptores e enzimas relacionadas à síntese de neurotransmissores no corpo estriado por PCR-RT revelou que o HAL foi capaz de aumentar a expressão de receptores dopaminérgicos D1 e D2 e reduzir a expressão dos receptores muscarínicos M1. A expressão da tirosina hidroxilase (TH), passo limitante para a síntese de dopamina, se apresentou reduzida pelo HAL. Os dados sugerem que as vitamina do complexo B são capazes de prevenir as alterações induzidas pelo HAL apresentando, portanto, um papel promissor na prevenção de DO associada ao uso desta fármaco.
Tang, Jing Jing. "Intérêt du profil chromatographique des acides organiques urinaires pour le diagnostic de carences en vitamines du groupe B (B1, B2, B8, B12)". Nutrition humaine, 1993. http://www.theses.fr/1993NAN10258.
Testo completoMurray, Louise M. "Comparative study of vitamin B12 and holotranscobalamin or active B12 as a marker for vitamin B12 deficiency at Dr George Mukhari Hospital". Thesis, University of Limpopo (Medunsa Campus), 2012. http://hdl.handle.net/10386/774.
Testo completoAbstract Aim: This study was undertaken to compare the diagnostic sensitivity and specificity of total vitamin B 12 analyses to active B 12 (holoTC) analyses in a population of patients attending the Dr George Mukhari Hospital in Pretoria. Methods: Routine serum folate, full blood count (FBC), thyroid function test, homocysteine, serum total vitamin B 12 and active B 12 analyses were performed on 30 samples. Results: Serum folate was determined in all patients and 96% of the patients had a normal folate value. When looking at the FBC results it is important to note that three times as many males as females presented with anemia (36% versus 16%). Thyroid function tests were normal in 90% of patients. When the total vitamin B 12 test was preformed only 10% of patients tested positive for vitamin B 12 deficiency, in contrast to the active B12 analyses where 16% of patients tested positive for vitamin B12 deficiency. Both tests had a diagnostic sensitivity of 50%. The diagnostic specificity for total vitamin B12 was 93% in comparison with the 86% obtained by the active B12 analyses; when homocysteine was used as the true marker for vitamin B12 deficiency. Conclusion: Diagnostic sensitivity was the same and the total vitamin B12 test's specificity was better in comparison to the active B 12 analyses. Thus the active B 12 assay cannot be recommended for routine use, since it has no benefit.
Libri sul tema "B14"
Petz, Wolfgang, e Christa Siebert. Fe Organoiron Compounds Part B14. A cura di Jürgen Faust e Johannes Füssel. Berlin, Heidelberg: Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-662-06921-9.
Testo completoDessins français du XVIIe siècle: Inventaire de la collection de la Réserve du département des Estampes et de la Photographie (cotes B6, B7, B11, B14). Paris: Bibliothèque nationale de France, 2014.
Cerca il testo completoRowlands, Gareth. Modular biology: Units B11 and B12 : AS Level. Cardiff: Welsh Joint Education Committee, 2001.
Cerca il testo completoZöllner, N., H. Fassl, I. Jurna, K. F. Pietrzik e M. Schattenkirchner, a cura di. Klinische Bedeutung von Vitamin B1, B6, B12 in der Schmerztherapie. Heidelberg: Steinkopff, 1988. http://dx.doi.org/10.1007/978-3-642-72427-5.
Testo completoSchneider, Zenon, e Andrzej Stroinski. Comprehensive B12. Berlin, Boston: DE GRUYTER, 1987. http://dx.doi.org/10.1515/9783110844795.
Testo completoEuropean Symposium on Vitamin B12 and B12-Proteins (4th 1996 Innsbruck, Austria). Vitamin B12 and B12-proteins: Lectures presented at the 4th European Symposium on Vitamin B12 and B12-Proteins. Weinheim: Wiley-VCH, 1998.
Cerca il testo completoInternational Symposium on Biomedicine and Physiology of Vitamin B12. (1st 1988 London, England). Biomedicine and physiology of vitamin B12: Proceedings of the First International Symposium, Charing Cross & Westminster Medical School, University of London, 26-29 September 1988. A cura di Bhatt H. R e Linnell J. C. London: The Children's Medical Charity, 1990.
Cerca il testo completo1939-, Stroiński Andrzej, a cura di. Comprehensive B12: Chemistry, biochemistry, nutrition, ecology, medicine. Berlin: De Gruyter, 1987.
Cerca il testo completoI͡Urkevich, A. M. Struktura, svoĭstva i mekhanizm deĭstvii͡a kobalaminovykh kofermentov. Moskva: VINITI, 1985.
Cerca il testo completoCapitoli di libri sul tema "B14"
Carachi, Robert. "B14 Burr Holes". In Basic Techniques in Pediatric Surgery, 157–58. Berlin, Heidelberg: Springer Berlin Heidelberg, 2013. http://dx.doi.org/10.1007/978-3-642-20641-2_46.
Testo completoKok, K., J. Houweling, A. C. L. M. Zuiderwijk, Y. G. van Ingen e M. Karels. "B14 Pathologie van het hormoonstelsel". In Anatomie, fysiologie en pathologie, 345–53. Houten: Bohn Stafleu van Loghum, 2016. http://dx.doi.org/10.1007/978-90-368-1227-6_31.
Testo completoKok, K., J. Houweling, A. C. L. M. Zuiderwijk, Y. G. van Ingen e M. Karels. "B14 Pathologie van het hormoonstelsel". In Anatomie, fysiologie en pathologie, 345–53. Houten: Bohn Stafleu van Loghum, 2016. http://dx.doi.org/10.1007/978-90-368-1228-3_31.
Testo completoPetz, Wolfgang, e Christa Siebert. "Compounds of the C5H5Fe(CO)2 1L Type (continued)". In Fe Organoiron Compounds Part B14, 1–50. Berlin, Heidelberg: Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-662-06921-9_1.
Testo completoPetz, Wolfgang, e Christa Siebert. "Other Compounds of the 5LFe(CO)2 1L Type". In Fe Organoiron Compounds Part B14, 51–85. Berlin, Heidelberg: Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-662-06921-9_2.
Testo completoPetz, Wolfgang, e Christa Siebert. "Anions of the Type [5LFe(CO)2]- and Their Salts". In Fe Organoiron Compounds Part B14, 85–124. Berlin, Heidelberg: Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-662-06921-9_3.
Testo completoPetz, Wolfgang, e Christa Siebert. "Cations of the [5LFe(CO)2]+ Type and Radicals of the 5LFe(CO)2 Type". In Fe Organoiron Compounds Part B14, 124–25. Berlin, Heidelberg: Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-662-06921-9_4.
Testo completoPetz, Wolfgang, e Christa Siebert. "Cations of the [5LFe(CO)2 1L]+ Type". In Fe Organoiron Compounds Part B14, 125–59. Berlin, Heidelberg: Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-662-06921-9_5.
Testo completoPetz, Wolfgang, e Christa Siebert. "Anions of the [5LFe(CO)2 1L]+ Type". In Fe Organoiron Compounds Part B14, 159–64. Berlin, Heidelberg: Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-662-06921-9_6.
Testo completoPetz, Wolfgang, e Christa Siebert. "Radical Ions Derived from 5LFe(CO)2 1L Compounds". In Fe Organoiron Compounds Part B14, 164–65. Berlin, Heidelberg: Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-662-06921-9_7.
Testo completoAtti di convegni sul tema "B14"
Schlappe, Brooke, Jennifer J. Mueller, Narciso Olvera, Fanny Dao, Cyriac Kandoth, Faina Bogomolniy, Agnes Viale et al. "Abstract B14: Molecular characterization of mucinous ovarian carcinoma." In Abstracts: AACR Special Conference: Advances in Ovarian Cancer Research: Exploiting Vulnerabilities; October 17-20, 2015; Orlando, FL. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1557-3265.ovca15-b14.
Testo completoRajakulendran, Nishani, Hayden Selvadurai, Katherine Rowland, Nicole Park, Nizar Batada, Peter Dirks e Stephane Angers. "Abstract B14: Wnt signaling circuits in glioblastoma multiforme". In Abstracts: AACR Special Conference on Developmental Biology and Cancer; November 30 - December 3, 2015; Boston, Massachusetts. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1557-3125.devbiolca15-b14.
Testo completo"B14. Compact Ultra Wideband Microstrip-Fed Printed Monopole Antenna". In 2013 30th National Radio Science Conference (NRSC). IEEE, 2013. http://dx.doi.org/10.1109/nrsc.2013.6587909.
Testo completoNeil, Kayli E., Sarah J. Lacroix, David F. Walker, Suhu Liu, David A. Frank e Sarah R. Walker. "Abstract B14: Atovaquone targets STAT3 in ovarian cancer spheroids". In Abstracts: AACR Special Conference on Advances in Ovarian Cancer Research; September 13-16, 2019; Atlanta, GA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1557-3265.ovca19-b14.
Testo completoAnglesio, Michael S., Aline Talhouk, Steve E. Kalloger, Gholamreza Haffari, Robertson Mackenzie, Martin Cheung, Janine Senz et al. "Abstract B14: Rapid RNA-based histotyping of ovarian carcinomas". In Abstracts: AACR Special Conference on Advances in Ovarian Cancer Research: From Concept to Clinic; September 18-21, 2013; Miami, FL. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1078-0432.ovca13-b14.
Testo completoWeige, Charles C., Changlong Liu, Erin L. Anderson, Carolyn E. Banister, Joseph Richardson, Carlo Contreras e Phillip J. Buckhaults. "Abstract B14: TP53 synthetic lethal targets in colon cancer". In Abstracts: AACR Special Conference: Colorectal Cancer: From Initiation to Outcomes; September 17-20, 2016; Tampa, FL. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.crc16-b14.
Testo completoElboushi, Ayman, e Abdelrazik Sebak. "B14. Active millimeter-wave imaging system for hidden weapons detection". In 2012 29th National Radio Science Conference (NRSC). IEEE, 2012. http://dx.doi.org/10.1109/nrsc.2012.6208514.
Testo completoXu, Mai, Albert C. Lockhart, Robert J. Myerson, Imran Zoberi, Gerald P. Linette e Andrea Wang-Gillam. "Abstract B14: A novel strategy for the treatment of melanoma". In Abstracts: AACR Special Conference on Advances in Melanoma: From Biology to Therapy; September 20-23, 2014; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.mel2014-b14.
Testo completoFord, Marvella E., Nestor F. Esnaola, Chris Finney, Katherine R. Sterba, Melanie S. Jefferson, Kent Armeson e Jane Zapka. "Abstract B14: Racial differences in colorectal cancer surveillance in South Carolina". In Abstracts: AACR International Conference on Frontiers in Cancer Prevention Research‐‐ Oct 22-25, 2011; Boston, MA. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1940-6207.prev-11-b14.
Testo completoDudgeon, Crissy, Jeffrey Rosenfeld, Eric Collisson e Darren Carpizo. "Abstract B14: The expression landscape of pancreatic cancer recurrence following resection". In Abstracts: AACR Special Conference on Tumor Metastasis; November 30-December 3, 2015; Austin, TX. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.tummet15-b14.
Testo completoRapporti di organizzazioni sul tema "B14"
Plaschkes, Michael, e Kibutz Magen. IEA-SHC Task 39 INFO Sheet B14 - Ideas for design and manufacturing of plastic storage tanks. IEA Solar Heating and Cooling Programme, maggio 2015. http://dx.doi.org/10.18777/ieashc-task39-2015-0014.
Testo completoDyer, A. BT14 reference guide. Office of Scientific and Technical Information (OSTI), settembre 1993. http://dx.doi.org/10.2172/10187021.
Testo completoGuangbai, Ma, Su Shiqiang e Stephan Fischer. INFO Sheet B04: Manufacturing Costs. IEA SHC Task 54, ottobre 2018. http://dx.doi.org/10.18777/ieashc-task54-2018-0010.
Testo completoBarnes, P. D. B1 magnet harmonics. Office of Scientific and Technical Information (OSTI), maggio 2000. http://dx.doi.org/10.2172/15005727.
Testo completoRekstad, John. IEA-SHC Task 39 INFO Sheet B16 - AventaSolar collector system. IEA Solar Heating and Cooling Programme, maggio 2015. http://dx.doi.org/10.18777/ieashc-task39-2015-0005.
Testo completoKhater, Hesham. Radiation Safety Analysis for the NI System in B194 [PowerPoint]. Office of Scientific and Technical Information (OSTI), maggio 2018. http://dx.doi.org/10.2172/1460073.
Testo completoMAYRHOFER, Susanne, e Alexander LUKENEDER. 3D Modellierung eines Karnischen Ammoniten-Massenvorkommens (Taurus, Türkei; FWF P22109-B17). Cogeo@oeaw-giscience, giugno 2010. http://dx.doi.org/10.5242/cogeo.2010.0006.
Testo completoBleuel, D. L., S. Anderson, J. A. Caggiano, J. M. Hall, M. Johnson, A. Ratkiewicz e B. Rusnak. Alternatives to argon for gas stopping volumes in the B194 neutron imager. Office of Scientific and Technical Information (OSTI), maggio 2017. http://dx.doi.org/10.2172/1358305.
Testo completoCooper, G. Tier 2 safety Basis Document for the B151 Complex (B151, B152, and B154). Office of Scientific and Technical Information (OSTI), dicembre 2006. http://dx.doi.org/10.2172/900884.
Testo completoReiter, Christoph, Dr Sebastian Brandmayr, Dr Christoph Trinkl e Prof Dr Ing Wilfried Zörner. IEA-SHC Task 39 INFO Sheet B12 - Conceptual solar domestic hot water systems. IEA Solar Heating and Cooling Programme, maggio 2015. http://dx.doi.org/10.18777/ieashc-task39-2015-0010.
Testo completo